SCHEMBL1038528

SCHEMBL1038528

CN(C)c1ccc(P(Br)Br)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.39
TSHR P16473 5/20 0.39
HSD17B10 Q99714 3/20 0.39
ALOX15 P16050 2/20 0.39
APP P05067 3/20 0.36
TERT O14746 1/20 0.36
KCNH2 Q12809 2/20 0.33
MAT2A P31153 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 4/20 0.32
CYP3A4 P08684 2/20 0.32
MAPK1 P28482 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
TP53 P04637 1/20 0.32
HPGD P15428 2/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1043007 0.84 ALDH1A1 (0.39) ALDH1A1TSHRHSD17B10ALOX15APP
SCHEMBL1041098 0.80 ALDH1A1 (0.39) ALDH1A1TSHRHSD17B10ALOX15APP
SCHEMBL1041640 0.76 AR (0.42) ALDH1A1TSHRHSD17B10ALOX15APP
SCHEMBL7692723 0.73 ALDH1A1 (0.50) ALDH1A1TSHRHSD17B10ALOX15APP
SCHEMBL1077214 0.72 ALDH1A1 (0.43) ALDH1A1TSHRHSD17B10ALOX15APP
SCHEMBL1039757 0.72 AR (0.42) ALDH1A1TSHRHSD17B10ALOX15APP
SCHEMBL19425812 0.70 ALDH1A1 (0.46) ALDH1A1TSHRHSD17B10ALOX15APP
SCHEMBL1076934 0.68 ALDH1A1 (0.43) ALDH1A1TSHRHSD17B10ALOX15APP
SCHEMBL23089861 0.68 ALDH1A1 (0.43) ALDH1A1TSHRHSD17B10ALOX15APP
SCHEMBL1041171 0.68 ALDH1A1 (0.43) ALDH1A1TSHRHSD17B10ALOX15APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915455-B2 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-03-29 US disclosed
EP-2272852-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex Sumitomo Chemical Company, Limited (JP) 2011-01-12 EP disclosed
US-20090143620-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED 2009-06-04 US disclosed
US-7482414-B2 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-27 US disclosed
US-20070135600-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-14 US disclosed
EP-1683802-A1 TRANSITION METAL COMPLEX LIGAND AND OLEFIN POLYMERIZATION CATALYST CONTAINING TRANSITION METAL COMPLEX Sumitomo Chemical Company, Limited (JP) 2006-07-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135600-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex AP1M1, OR10J3, AP2M1 ALDH1A1 4017/4885TSHR 1198/4885HSD17B10 3246/4885
US-20090143620-A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex AP1M1, OR10J3, AP2M1 ALDH1A1 4017/4885TSHR 1198/4885HSD17B10 3246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.